Daniel N. Swisher
Equibles does not estimate personal net worth.
Get an email with a short summary when Corcept Therapeutics Inc publishes a filing, an earnings call transcript or a press release.
Get CORT alertsAbout Daniel N. Swisher
Daniel N. Swisher is recorded as COO at Corcept Therapeutics Inc (CORT). The newest filing on record that lists Daniel N. Swisher as COO at Corcept Therapeutics Inc (CORT) is dated April 17, 2026. Corcept Therapeutics Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Corcept Therapeutics Inc includes Joseph K. Belanoff (CEO and Board Member), James N. Wilson (Chairman and Board Member), Atabak Mokari (CFO) and 7 others.
Affiliation history
-
Current
Start not stated–present
Last confirmed April 17, 2026
-
Start not stated–2025-04-25
Last confirmed by a filing; no departure on record
Company network
Leadership on record at Corcept Therapeutics Inc
- Joseph K. Belanoff CEO, Board Member
- James N. Wilson Chairman, Board Member
- Atabak Mokari CFO
- Joshua M. Murray CFO, Head of Investor Relations, Board Member
- J.D. Lyon Chief Accounting Officer
- Joseph D. Lyon Chief Accounting Officer
- Daniel N. Swisher, Jr. Board Member
- David L. Mahoney Board Member
- G. Leonard Baker, Jr. Board Member
- Gillian M. Cannon, PhD Board Member
Recent activity
No call appearances or filed executive changes recorded yet.